Finance

Lists
AVE:ASX
Avecho Biotechnology Ltd
A$0.013
0.00%
(0.00) 1D
Nov 5, 4:10:30 PM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AVE...
Mkt. cap
65.30M
Avg. vol.
4.48M
Volume
0.00
52-wk high
A$0.03
52-wk low
A$0.00
EPS
-A$0.00
Shares outstanding
3.86B
No. of employees
15
Mkt. cap
65.30M
Avg. vol.
4.48M
Volume
0.00
52-wk high
A$0.03
52-wk low
A$0.00
EPS
-A$0.00
Shares outstanding
3.86B
No. of employees
15
News stories
From web sources and news partners
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteavecho.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
338.85K
338.85K
29.80K
29.80K
Cost of goods sold
92.11K
92.11K
7.76K
7.76K
Cost of revenue
92.11K
92.11K
7.76K
7.76K
Research and development expenses
478.93K
478.93K
221.87K
221.87K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
441.76K
441.76K
737.40K
737.40K
Operating expense
920.69K
920.69K
959.27K
959.27K
Total operating expenses
1.01M
1.01M
967.03K
967.03K
Operating income
-673.96K
-673.96K
-937.23K
-937.23K
Other non operating income
-
-
-
-
EBT including unusual items
-870.33K
-870.33K
-961.82K
-961.82K
EBT excluding unusual items
-870.33K
-870.33K
-961.82K
-961.82K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-870.33K
-870.33K
-961.82K
-961.82K
Net profit margin
-256.85%
-256.85%
-3,227.46%
-3,227.46%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-196.38K
-196.38K
-24.59K
-24.59K
Net interest expenses
-196.38K
-196.38K
-24.59K
-24.59K
Depreciation and amortization charges
-
-
-
-
EBITDA
-639.62K
-639.62K
-909.80K
-909.80K
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps